Contrasting the Influence of Cationic Amino Acids on the Viscosity and Stability of a Highly Concentrated Monoclonal Antibody
暂无分享,去创建一个
Thomas M. Truskett | Keith P. Johnston | Thomas M Truskett | Barton J. Dear | J. Hung | K. Johnston | Jessica J. Hung | Barton Dear
[1] Feng He,et al. Effect of Sugar Molecules on the Viscosity of High Concentration Monoclonal Antibody Solutions , 2011, Pharmaceutical Research.
[2] T. Arakawa,et al. The stabilization of proteins by osmolytes. , 1985, Biophysical journal.
[3] Brian K. Wilson,et al. Concentrated dispersions of equilibrium protein nanoclusters that reversibly dissociate into active monomers. , 2012, ACS nano.
[4] H. Epstein,et al. Optical methods for measuring nucleoprotein and nucleic acid concentrations. , 1957, Archives of biochemistry and biophysics.
[5] Mark Teeters,et al. Predicting diafiltration solution compositions for final ultrafiltration/diafiltration steps of monoclonal antibodies , 2011, Biotechnology and bioengineering.
[6] Anuj Chaudhri,et al. Highly viscous antibody solutions are a consequence of network formation caused by domain-domain electrostatic complementarities: insights from coarse-grained simulations. , 2015, Molecular pharmaceutics.
[7] Sandeep Yadav,et al. Weak interactions govern the viscosity of concentrated antibody solutions: high-throughput analysis using the diffusion interaction parameter. , 2012, Biophysical journal.
[8] Thomas M Truskett,et al. Coarse-grained strategy for modeling protein stability in concentrated solutions. , 2005, Biophysical journal.
[9] Feng Qian,et al. Viscosity-Lowering Effect of Amino Acids and Salts on Highly Concentrated Solutions of Two IgG1 Monoclonal Antibodies. , 2015, Molecular pharmaceutics.
[10] Steven Kozlowski,et al. Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. , 2009, Journal of pharmaceutical sciences.
[11] M. Mulkerrin,et al. Influence of Histidine on the Stability and Physical Properties of a Fully Human Antibody in Aqueous and Solid Forms , 2003, Pharmaceutical Research.
[12] Steven J Shire,et al. Challenges in the development of high protein concentration formulations. , 2004, Journal of pharmaceutical sciences.
[13] Roger A. Nassar,et al. Structure-Activity Relationship for Hydrophobic Salts as Viscosity-Lowering Excipients for Concentrated Solutions of Monoclonal Antibodies , 2012, Pharmaceutical Research.
[14] S. Sandler,et al. Anisotropic Contributions to Protein-Protein Interactions. , 2014, Journal of chemical theory and computation.
[15] Thomas M. Truskett,et al. Tunable equilibrium nanocluster dispersions at high protein concentrations , 2013 .
[16] D. Kalonia,et al. Long- and Short-Range Electrostatic Interactions Affect the Rheology of Highly Concentrated Antibody Solutions , 2009, Pharmaceutical Research.
[17] Gregory A Voth,et al. The role of amino acid sequence in the self-association of therapeutic monoclonal antibodies: insights from coarse-grained modeling. , 2013, The journal of physical chemistry. B.
[18] Jirí Vondrásek,et al. The molecular origin of like-charge arginine-arginine pairing in water. , 2009, The journal of physical chemistry. B.
[19] M. Blanco,et al. Role of Anisotropic Interactions for Proteins and Patchy Nanoparticles , 2014, The journal of physical chemistry. B.
[20] J. Heyda,et al. Attractive interactions between side chains of histidine-histidine and histidine-arginine-based cationic dipeptides in water. , 2010, The journal of physical chemistry. B.
[21] Q. Du,et al. Energies and physicochemical properties of cation-π interactions in biological structures. , 2012, Journal of molecular graphics & modelling.
[22] T. Scherer. Role of Cosolute-Protein Interactions in the Dissociation of Monoclonal Antibody Clusters. , 2015, The journal of physical chemistry. B.
[23] C. Moriyama,et al. Quantitative Correlation between Viscosity of Concentrated MAb Solutions and Particle Size Parameters Obtained from Small-Angle X-ray Scattering , 2015, Pharmaceutical Research.
[24] B. Trout,et al. Interaction of arginine with proteins and the mechanism by which it inhibits aggregation. , 2010, The journal of physical chemistry. B.
[25] P. Carter. Potent antibody therapeutics by design , 2006, Nature Reviews Immunology.
[26] E. Takai,et al. Arginine and lysine reduce the high viscosity of serum albumin solutions for pharmaceutical injection. , 2014, Journal of bioscience and bioengineering.
[27] Sandeep Yadav,et al. Solubility Challenges in High Concentration Monoclonal Antibody Formulations: Relationship with Amino Acid Sequence and Intermolecular Interactions. , 2015, Molecular pharmaceutics.
[28] Linda O. Narhi,et al. Anion Binding Mediated Precipitation of a Peptibody , 2008, Pharmaceutical Research.
[29] F. Agnely,et al. Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[30] Steven M Cramer,et al. Mobile phase modifier effects in multimodal cation exchange chromatography , 2012, Biotechnology and bioengineering.
[31] Christopher J Roberts,et al. Protein aggregation and its impact on product quality. , 2014, Current opinion in biotechnology.
[32] Junfen Ma,et al. Intermolecular Interactions and the Viscosity of Highly Concentrated Monoclonal Antibody Solutions , 2015, Pharmaceutical Research.
[33] Li Li,et al. Concentration Dependent Viscosity of Monoclonal Antibody Solutions: Explaining Experimental Behavior in Terms of Molecular Properties , 2014, Pharmaceutical Research.
[34] Isidro E Zarraga,et al. High shear rheology and anisotropy in concentrated solutions of monoclonal antibodies. , 2013, Journal of pharmaceutical sciences.
[35] Thomas M. Truskett,et al. Viscosity Reduction of a Concentrated Monoclonal Antibody with Arginine·HCl and Arginine·Glutamate , 2016 .
[36] Kouhei Tsumoto,et al. Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects. , 2007, Biophysical chemistry.
[37] S. Shire,et al. Monoclonal Antibody Self-Association, Cluster Formation, and Rheology at High Concentrations , 2014 .
[38] Hanns‐Christian Mahler,et al. Rheological characterization and injection forces of concentrated protein formulations: an alternative predictive model for non-Newtonian solutions. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[39] Steven M Cramer,et al. Evaluation of selectivity in multimodal anion exchange systems: a priori prediction of protein retention and examination of mobile phase modifier effects. , 2011, Journal of chromatography. A.
[40] Steven J Shire,et al. Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution. , 2005, Journal of pharmaceutical sciences.
[41] A. Fersht,et al. Histidine-aromatic interactions in barnase. Elevation of histidine pKa and contribution to protein stability. , 1992, Journal of molecular biology.
[42] Wei Wang,et al. Advanced protein formulations , 2015, Protein science : a publication of the Protein Society.
[43] C. Horváth,et al. Salt effect on hydrophobic interactions in precipitation and chromatography of proteins: an interpretation of the lyotropic series. , 1977, Archives of biochemistry and biophysics.
[44] Sandeep Yadav,et al. Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies. , 2010, Journal of pharmaceutical sciences.
[45] Steven J Shire,et al. Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity. , 2008, Journal of pharmaceutical sciences.
[46] Bernhardt L Trout,et al. Protein-associated cation clusters in aqueous arginine solutions and their effects on protein stability and size. , 2013, ACS chemical biology.
[47] Thomas M Truskett,et al. Coarse-grained strategy for modeling protein stability in concentrated solutions. II: phase behavior. , 2006, Biophysical journal.
[48] E. Takai,et al. Specific decrease in solution viscosity of antibodies by arginine for therapeutic formulations. , 2014, Molecular pharmaceutics.
[49] Thomas M Truskett,et al. High concentration tangential flow ultrafiltration of stable monoclonal antibody solutions with low viscosities , 2016 .
[50] Shaoyi Jiang,et al. Ultralow‐Fouling, Functionalizable, and Hydrolyzable Zwitterionic Materials and Their Derivatives for Biological Applications , 2010, Advanced materials.
[51] Gregory A Voth,et al. Coarse-grained modeling of the self-association of therapeutic monoclonal antibodies. , 2012, The journal of physical chemistry. B.
[52] Norman J Wagner,et al. Observation of small cluster formation in concentrated monoclonal antibody solutions and its implications to solution viscosity. , 2014, Biophysical journal.